Barclay Buck A. Phillips

2019

In 2019, Barclay Buck A. Phillips earned a total compensation of $1.2M as Former Chief Financial Officer and Senior Vice President, Corporate Development at G1 Therapeutics, a 70% increase compared to previous year.

Compensation breakdown

Option Awards$828,484
Salary$136,024
Other$247,453
Total$1,211,962

Phillips received $828.5K in option awards, accounting for 68% of the total pay in 2019.

Phillips also received $136K in salary and $247.5K in other compensation.

Rankings

In 2019, Barclay Buck A. Phillips' compensation ranked 8,381st out of 13,971 executives tracked by ExecPay. In other words, Phillips earned more than 40.0% of executives.

ClassificationRankingPercentile
All
8,381
out of 13,971
40th
Division
Manufacturing
3,316
out of 5,701
42nd
Major group
Chemicals And Allied Products
1,256
out of 2,200
43rd
Industry group
Drugs
1,067
out of 1,886
43rd
Industry
Pharmaceutical Preparations
792
out of 1,398
43rd

Pay ratio

Barclay Buck A. Phillips' Pay$1,211,962
Median Employee's Pay$213,060
Pay Ratio

6

to 1

In 2019, the annual total compensation of Barclay Buck A. Phillips was $1,211,962.

The annual total compensation of the median employee at G1 Therapeutics was $213,060.

The ratio of Barclay Buck A. Phillips' pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 24, 2020.

Phillips' colleagues

We found five more compensation records of executives who worked with Barclay Buck A. Phillips at G1 Therapeutics in 2019.

2019

Mark Avagliano

G1 Therapeutics

Chief Business Officer

2019

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2019

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

2019

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

2019

John Demaree

G1 Therapeutics

Chief Commercial Officer

News

In-depth

You may also like